RT @weldeiry: Molecular analysis of 80405 #asco17 https://t.co/HUu45dMMPX
8:39pm June 5th 2017 via Twitter Web Client
RT @weldeiry: Interesting results from analysis #asco17 https://t.co/ahI4Ydl9Zb
RT @weldeiry: More intriguing results from 80405 analysis #asco17 https://t.co/L1G0lrgR2d
8:37pm June 5th 2017 via Twitter Web Client
RT @OfficialJoelF: The youngest developer at WWDC is just 10 y old; started coding at the age of 6 and has 5 apps in the App Store #WWDC17
8:20pm June 5th 2017 via Hootsuite
Prostate cancer trial stuns researchers: 'It's a once in a career feeling' |#ASCO17 The Guardian https://t.co/yfLW3KeveG
8:04pm June 5th 2017 via Hootsuite
RT @moorejh: #apple #machinelearning https://t.co/O1AKKHWdLL
7:25pm June 5th 2017 via Hootsuite
RT @harrymccracken: Apple introducing ARKit, to help developers build augmented-reality apps that use the iPhone camera. https://t.co/DDL6z…
4:44pm June 5th 2017 via Hootsuite
RT @harrymccracken: Here you go: two HomePods. They're quite large. https://t.co/GGZDweGwRB
RT @ICR_London: Cancer blood test that detects disease years ahead of symptoms 'could save thousands of lives' – via @Independent https://t…
4:42pm June 5th 2017 via Hootsuite
Grail passes early test in quest to find cancer in blood | Yahoo Finance https://t.co/vHmso9ikY2
4:20pm June 5th 2017 via Hootsuite
A Radical Proposal For Preventing Rare Genetic Diseases | Wired https://t.co/Yawkz5nRse
3:03pm June 5th 2017 via Hootsuite
AstraZeneca's Lynparza Slows Breast Cancer Caused By BRCA Mutations By 42% | Forbes https://t.co/cnwVMG4x5H
11:30am June 5th 2017 via Hootsuite
If This Were a Drug, the Price Would Be $100,000 | Medscape #ASCO17 https://t.co/5sTpfRsTYq
10:45am June 5th 2017 via Hootsuite
'Striking Results' in All Cancer Types: Larotrectinib | Medscape #ACSO17 https://t.co/qT8kofIqcy
9:45am June 5th 2017 via Hootsuite
Genentech: Clinical Trial Challenge https://t.co/ZYm4NCRQSR
8:20am June 5th 2017 via Hootsuite
RT @barlesi: Tumor heterogeity in the design of #PrecisionMedicine trials. Another matter of debate #ASCO17 https://t.co/FEyOtzy4HI
6:50am June 5th 2017 via Hootsuite
RT @dhjutsw1: #ASCO17 $ toxicity session well attended. Docs increasingly worried pts denied care b/o cost of care. https://t.co/29JU29Eo9a
5:50am June 5th 2017 via Hootsuite
MT @APHealthScience: An online tool that lets cancer patients report side effects improved survival. #ASCO17 https://t.co/mgrL9vXtMZ
10:45pm June 4th 2017 via Hootsuite
RT @bradloncar: #ASCO17 news scorecard so far:
8:57pm June 4th 2017 via Hootsuite
RT @DrKhouryCDC: The case against universal genomic testing to win the war against cancer. @JAMAOnc https://t.co/Neh34njXMj #ASCO17 https:…
8:54pm June 4th 2017 via Hootsuite
RT @ajumathew_: Never underestimate gr 6 science project winners. They could turn out to be a Brian Druker #ASCO17 https://t.co/Hj5USjvBlC
8:45pm June 4th 2017 via Hootsuite
RT @KidneyCancer: #ASCO17 highlights of the day: https://t.co/3R1SJPQsE6
7:45pm June 4th 2017 via Hootsuite
RT @barlesi: What a good comprehensive review on liquid biopsies by Alice Shaw. Thanks to #ASCO17 https://t.co/KLkWSGsO5p
6:25pm June 4th 2017 via Hootsuite
RT @StoverLab: Our work on cell free DNA in metastatic #TNBC @ASCO #ASCO2017 https://t.co/YEpKjDZu91
6:00pm June 4th 2017 via Hootsuite
RT @CancerNetwrk: Olaparib improves outcomes in BRCA-mutated metastatic #breastcancer https://t.co/aBQas1sQXA #ASCO17 #ASCO2017
4:54pm June 4th 2017 via Hootsuite
RT @anukPDX: Practice changing data #ASCO2017 #DrMarkRobson & OlympiAD investigators PARP inhibitor olaparib in BRCA+ Metastatic Breast
RT @marinagarassino: #OlimpiAD #ASCO2017 #olaparib https://t.co/DRzsL6I9w2
RT @OncologyAdvance: High impact Oncology research all in one place, free for you to read for a limited time #ASCO2017 https://t.co/JtOfqE…
4:50pm June 4th 2017 via Hootsuite
RT @MeganKruseMD: Exciting improvement in PFS for metastatic breast cancer patients with BRCA mutations receiving olaparib v chemo. #ASCO20…
4:49pm June 4th 2017 via Hootsuite
The Specialists’ Stranglehold on Medicine - NYTimes https://t.co/cnRIVVez1y
1:30pm June 4th 2017 via Hootsuite
Genomics and... Happiness? - The New Yorker https://t.co/ehSfyWQgpP
1:10pm June 4th 2017 via Hootsuite
The Doctor Is In. Co-Pay? $40,000. - NYTimes https://t.co/GZ81ZS2KxR
12:30pm June 4th 2017 via Hootsuite
Should we be worried about CRISPR/Cas9 off target effects? | Medium https://t.co/XW0cM4Y3SV
11:50am June 4th 2017 via Hootsuite
Crack in CRISPR Facade after Unanticipated In Vivo Mutations Arise | GEN https://t.co/PFhTWDupG6
11:15am June 4th 2017 via Hootsuite
Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing | PR Newswire https://t.co/nfq1iqYrKq
10:10am June 4th 2017 via Hootsuite
RT @breelynwilky: I am literally printing this out and putting it on my wall @drkomanduri @JTrentMDPhD https://t.co/o356YWbSKD
9:50am June 4th 2017 via Hootsuite
RT @GrantWilliamsMD: The silver oncologic tsunami, are we ready? #ASCO17 #gerionc https://t.co/WT8NWlh4fX
8:45am June 4th 2017 via Hootsuite
RT @mtmdphd: #ASCO17 @hoosierdfh 38,004 attendees at this @ASCO Annual Meeting https://t.co/hKoCYzIDT5
7:37am June 4th 2017 via Hootsuite
Agilent Technologies and Agendia Sign Agreement on Molecular Cancer Diagnostics | Business Wire https://t.co/4ZHdpYAGSL
7:22am June 4th 2017 via Hootsuite
RT @DrLizMorris: Whatever the work is, do it well—not for the boss but for yourself https://t.co/0brsVbXj0c via @newyorker
6:15am June 4th 2017 via Hootsuite
RT @DrLizMorris: Great #liquidbiopsy session @ASCO “#tissue #CTC & #ctDNA give complimentary info” D Hayes #ASCO17 https://t.co/8LQqGLLc
5:05am June 4th 2017 via Hootsuite
Thermo Fisher's New Genetic Analyzer Provides Makeover for Sanger Sequencing, Fragment Analysis | GenomeWeb ($) https://t.co/281tjpOMeU
10:40pm June 3rd 2017 via Hootsuite
RT @hoperugo: Great talk by Leisha Emens on TNBC, parp and PD1 inhib. #ASCO17 https://t.co/udfdEclXzw
10:00pm June 3rd 2017 via Hootsuite
RT @perth_meso_dr: Costs of these #immunoOncology drugs over 6 weeks almost identical. ?coincidence? #ASCO17 https://t.co/t4GREQtYD9
9:40pm June 3rd 2017 via Hootsuite
RT @Intermountain: How and When to Implement Precision Oncology https://t.co/rr7a5beXY4 #ASCO17 #precisionmedicine @ASCO
8:40pm June 3rd 2017 via Hootsuite
RT @DrHedrick: June: The CAR-T Ecosystem. #ASCO17 https://t.co/JcDW4yXiaC
7:40pm June 3rd 2017 via Hootsuite
RT @matthewherper: Writing this story made me cry. #ASCO17 $LOXO https://t.co/8ZKMkxULqd
6:35pm June 3rd 2017 via Hootsuite
Two Research Groups Develop Droplet Microfluidic Techniques for Single-Cell Sequencing | Genomeweb ($) https://t.co/TCEHbdqhyt
6:17pm June 3rd 2017 via Buffer
RT @drdgoldstein: We can save $0.8 billion annually just by giving 2mg/kg of pembro instead of 200mg fixed. #ASCO17 poster brd 339. publish…
5:53pm June 3rd 2017 via Hootsuite
RT @VinayPrasad82: WOW; @ShamMailankody shows modern myeloma DRUGS may cost 1 million dollars per person This is Pharma greed #asco17 https…
